Gritstone Bio Inc (GRTS)
0.7295
-0.01
(-1.91%)
USD |
NASDAQ |
Apr 19, 16:00
0.7295
0.00 (0.00%)
After-Hours: 20:00
Gritstone Bio Revenue (TTM): 1.332M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.332M |
| September 30, 2023 | 2.63M |
| June 30, 2023 | 2.705M |
| March 31, 2023 | 5.066M |
| December 31, 2022 | 9.269M |
| September 30, 2022 | 9.722M |
| June 30, 2022 | 11.69M |
| March 31, 2022 | 11.77M |
| December 31, 2021 | 46.72M |
| September 30, 2021 | 45.86M |
| Date | Value |
|---|---|
| June 30, 2021 | 44.25M |
| March 31, 2021 | 41.89M |
| December 31, 2020 | 3.463M |
| September 30, 2020 | 3.429M |
| June 30, 2020 | 3.618M |
| March 31, 2020 | 4.28M |
| December 31, 2019 | 4.365M |
| September 30, 2019 | 4.572M |
| June 30, 2019 | 3.684M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.332M
Minimum
Dec 2023
46.72M
Maximum
Dec 2021
13.70M
Average
4.572M
Median
Sep 2019
Revenue (TTM) Benchmarks
| Precision BioSciences Inc | 48.73M |
| Humacyte Inc | -- |
| Verastem Inc | -- |
| BioVie Inc | -- |
| Syros Pharmaceuticals Inc | 9.935M |